Home › Law Database › Argentina

Are peptides legal in Argentina?

Sourced guide to the legal status of peptides in Argentina, refreshed automatically from live research.

Overall Status: Restricted

Short answer: Peptides such as BPC-157, TB-500, and other injectable research peptides are not legally approved for sale or human use in Argentina, and ANMAT (the national medicines regulator) has publicly warned that unauthorized peptide products sold online and via WhatsApp lack any approval, quality control, or known manufacturer.

Important: This information is for educational purposes only and does not constitute legal advice. Laws and enforcement policies change. Consult a qualified attorney for specific legal guidance.

Overview

Peptides are restricted in Argentina: only specific peptide-based drugs formally registered with ANMAT (such as the GLP-1 medicine semaglutide, sold as Wegovy/Ozempic) are legal, and only as prescription-only medicines dispensed through pharmacies. Unregistered research peptides -- including BPC-157, TB-500, GHK, Ipamorelin/CJC-1295, Melanotan II, AOD-9604, DSIP, and retatrutide -- are not approved as medicinal specialties and their online/WhatsApp sale has been the subject of repeated ANMAT public alerts. All medicines, including peptides, fall under Argentina's general pharmaceutical law (Ley 16.463) administered by ANMAT, which governs import, production, and commercialization, and personal import of unregistered medicines is only possible through ANMAT's formal exceptional-access import regime, not informal online purchase.

Key Points

  • ANMAT has issued and repeatedly expanded a public alert stating that peptide-containing injectable products sold online and via WhatsApp -- including retatrutide, BPC-157, TB-500, GHK, Ipamorelin/CJC-1295, MOTS-S, Epitalon, Semax/Selank, Melanotan II, AOD-9604 and DSIP -- are not approved as medicinal specialties in Argentina. [1]
  • ANMAT states that because these unauthorized peptide products lack approval, the identity of their manufacturers, their exact composition, and their manufacturing conditions are unknown, so their quality, safety, and efficacy cannot be guaranteed. [4]
  • Semaglutide is legally available in Argentina only as a registered prescription medicine, after ANMAT authorized Novo Nordisk Pharma Argentina S.A. to register Wegovy (semaglutide) in the Registro de Especialidades Medicinales under Disposición N° 5591/2023. [2]
  • Wegovy (semaglutide) is dispensed in Argentina exclusively under medical prescription and follow-up, obtained only at pharmacies rather than sold over the counter. [3]
  • All pharmaceutical import, production, and commercialization activity in Argentina -- including for peptide-based products -- is subject to Ley 16.463 and its implementing ANMAT regulations, which place these activities under the national regulator's authorization regime. [7]
  • Personal importation of medicines not registered with ANMAT into Argentina is only permitted through ANMAT's formal 'Régimen de Accesibilidad de Excepción a Medicamentos' (exceptional-access import regime), which requires justification such as the absence of an equivalent treatment registered in the country, not informal purchase from foreign or online research-chemical vendors. [6]
  • ANMAT specifically warns that AOD-9604, a synthetic growth-hormone fragment peptide marketed for fat loss, showed no significant weight-loss benefit over placebo in a 24-week clinical trial of 536 people, undermining safety/efficacy claims made by illegal sellers. [5]
  • No Argentine statute or ANMAT disposition specifically legalizes personal use or possession of unregistered research peptides like BPC-157 or TB-500 for individuals; the general medicines law (Ley 16.463) treats their commercialization and import as subject to ANMAT authorization, which has not been granted for these compounds. [7]

Peptide-by-peptide status in Argentina

BPC-157BPC-157 is an unapproved research peptide in Argentina, explicitly named in ANMAT's public alert as an unauthorized injectable ingredient being illegally sold online and via WhatsApp without regulatory approval. [1]
Semaglutide (GLP-1, e.g. Wegovy/Ozempic)Semaglutide is a legal, prescription-only medicine in Argentina, registered by ANMAT under Disposición N° 5591/2023 as Wegovy for obesity/weight management in adults and adolescents from age 12, and dispensed only through pharmacies with a prescription. [2]
TB-500TB-500 is an unapproved research peptide in Argentina, named alongside BPC-157 in ANMAT's alert on illegally sold peptide injectables of unknown manufacture and unverified safety. [5]
Human Growth Hormone (HGH) / growth-hormone-related peptides (e.g. AOD-9604, Ipamorelin/CJC-1295)Growth-hormone-related peptide products such as AOD-9604 and Ipamorelin/CJC-1295 are unapproved and subject to the same ANMAT warning as other illegally marketed peptides, with ANMAT specifically noting that AOD-9604 failed to demonstrate meaningful weight-loss efficacy in human trials. [5]

Sources

Last researched: 2026-09-10

Frequently asked questions

Can I buy peptides like BPC-157 or TB-500 in Argentina without a prescription?
No -- BPC-157, TB-500, and similar research peptides have no ANMAT-approved medicinal registration in Argentina, so there is no legal over-the-counter or prescription channel for them, and ANMAT has publicly flagged their online and WhatsApp sale as unauthorized. [1]
Can I import peptides into Argentina for personal use?
Only through ANMAT's formal exceptional-access import regime for unregistered medicines, which requires a documented medical justification (such as no equivalent treatment available in the country); informally ordering research peptides online for personal import falls outside this legal pathway. [6]
Is semaglutide legal in Argentina for weight loss?
Yes -- semaglutide is legal in Argentina as the ANMAT-registered medicine Wegovy, approved as a complement to diet and exercise for adults and adolescents from age 12 with obesity or overweight plus a related comorbidity, but it is prescription-only and dispensed exclusively through pharmacies. [3]
What happens if peptides are sold illegally in Argentina -- does ANMAT take enforcement action?
ANMAT responds to illegal peptide sales primarily through public health alerts warning consumers that these unauthorized products' manufacturers, composition, and safety are unknown, and it asks the public to report points of sale, rather than through a peptide-specific criminal statute. [4]
Are peptides regulated as controlled/scheduled substances in Argentina like narcotics?
No specific national drug-scheduling law lists research peptides such as BPC-157 as controlled substances in Argentina; instead they are regulated indirectly through the general medicines framework of Ley 16.463, which requires ANMAT registration for any product to be legally manufactured, imported, or sold as a medicine, and unregistered peptides simply lack this authorization. [7]